Sustainability Report

Overview

The report presents Piramal Pharma's FY22 sustainability performance across its global pharma businesses, reporting 55,826 tCO2e of Scope 1 emissions, 90,709 tCO2e of Scope 2 emissions, and 1,418,899 GJ of total energy consumption. It highlights a 10% renewable-energy share, 853,012 kl of water consumed, and responsible waste practices including 10,891 MT of hazardous waste. Socially, it reports 6,130 employees, 30% female representation on the Board, and zero fatalities, alongside EHS training and community programs reaching 113 million beneficiaries to date.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services